HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$29.93
Day range
$28.26 - $30.56
Year range
$25.99 - $51.61
Market cap
1.80B USD
Avg Volume
971.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 48.91M | 80.98% |
Net income | -43.43M | -69.27% |
Net profit margin | — | — |
Earnings per share | -0.72 | -24.14% |
EBITDA | -48.89M | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 640.85M | 298.75% |
Total assets | 655.68M | 273.51% |
Total liabilities | 78.53M | 6.32% |
Total equity | 577.16M | — |
Shares outstanding | 60.69M | — |
Price to book | 3.15 | — |
Return on assets | -23.88% | — |
Return on capital | -25.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -43.43M | -69.27% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Headquarters
Website
Employees
82
